7月23日， 赛默飞世尔股价大涨超10%。
消息面上，公司第二季度营收约119.9亿美元，同比增长10%，高于市场预期的117亿美元；调整后每股收益（EPS）为6.03美元，高于市场预期的5.71美元。实验室产品与生物制药服务业务营收增长明显，生命科学解决方案业务也实现增长。
7月23日， 赛默飞世尔股价大涨超10%。
消息面上，公司第二季度营收约119.9亿美元，同比增长10%，高于市场预期的117亿美元；调整后每股收益（EPS）为6.03美元，高于市场预期的5.71美元。实验室产品与生物制药服务业务营收增长明显，生命科学解决方案业务也实现增长。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.